Trial intelligence / Profile preview

Dexmedetomidine and postoperative sleep architecture after laryngectomy in older ICU patients

ChiCTR2100051438Phase 4Not yet recruiting

Sponsor
Eye and ENT Hospital of Fudan University
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in sleep disorder comparing Dexmedetomidine infusion with Saline infusion (placebo control) (2 arms). Primary endpoints: percentage of N1 sleep, percentage of N2 sleep and 2 more. Planned start Oct 2021; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

sleep disorder

Beyond the preview

Go deeper on ChiCTR2100051438.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100051438.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call